IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
0.3000
-0.0010 (-0.33%)
At close: Apr 2, 2026, 4:00 PM EDT
0.3070
+0.0070 (2.33%)
After-hours: Apr 2, 2026, 7:57 PM EDT
IceCure Medical Employees
As of December 31, 2025, IceCure Medical had 69 total employees, including 67 full-time and 2 part-time employees. The number of employees increased by 3 or 4.55% compared to the previous year.
Employees
69
Change (1Y)
3
Growth (1Y)
4.55%
Revenue / Employee
$48,971
Profits / Employee
-$218,217
Market Cap
24.35M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 69 | 3 | 4.55% | 67 | 2 |
| Dec 31, 2024 | 66 | -11 | -14.29% | 64 | 2 |
| Dec 31, 2023 | 77 | 5 | 6.94% | 71 | 6 |
| Dec 31, 2022 | 72 | 8 | 12.50% | 65 | 7 |
| Dec 31, 2021 | 64 | 17 | 36.17% | 55 | 9 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Nortech Systems | 744 |
| TELA Bio | 209 |
| Myomo | 195 |
| Cytosorbents | 149 |
| IRIDEX | 93 |
| Adagio Medical Holdings | 80 |
| VolitionRx | 75 |
| Pulsenmore | 58 |
ICCM News
- 9 days ago - IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement - PRNewsWire
- 10 days ago - IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates - PRNewsWire
- 11 days ago - IceCure Appoints Meir Peleg as Chief Financial Officer - PRNewsWire
- 18 days ago - IceCure Reports 2025 Full Year Financial & Operational Results - PRNewsWire
- 24 days ago - U.S. FDA Approves IceCure's Post-Marketing "ChoICE" Study for ProSense® Cryoablation in the Local Treatment of Low-Risk Breast Cancer - PRNewsWire
- 25 days ago - IceCure Medical to Report 2025 Full Year Financial and Operating Results on March 17, 2026 - PRNewsWire
- 26 days ago - American Society of Breast Surgeons (ASBrS) Resource Guide Update Recommends Cryoablation for Low-Risk Breast Cancer - PRNewsWire
- 4 weeks ago - IceCure Medical Reports Independent Study Published in PLOS One Demonstrating ProSense® Cryoablation Safe and Effective in Treatment of Breast Fibroadenomas - PRNewsWire